一脈陽光(2522.HK)獲納入恒生綜合指數
恒生指數公司上週五盤後宣佈最新季檢結果顯示,一脈陽光(2522.HK)獲納入恒生綜合指數,變動將於2025年3月7日(星期五)收市後實施並於2025年3月10日(星期一)起生效。恒生綜合指數是一項全面的香港市場指標,涵蓋了在香港聯合交易所有限公司主板上市的公司總市值最高的95%,可以用作指數基金、互惠基金及業績表現的基準。市場人士認為,獲納入恒生綜合指數反映資本市場對公司業務表現及價值的高度認可,將有助擴大公司股東基礎並增加其股份交易的流通性,從而提高公司在資本市場的投資價值及聲譽。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.